Reagents for biochem antibiotics suscep 10/01/2023-09/30/2024
Ended Awarded Last action
- Contract number
- W81K0223F0108
- Awardee
-
Namu Med UEI FKMJKCM6K5A3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $41,667
Award facts
- Opportunity
-
- Biochemical Antibiotic Susceptibility Testings Solicitation · W81K0222Q0074 · Posted Jun 29, 2022
- Contract value 100% obligated
- $41,666.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$26,409 | |
| Supplemental Agreement for work within scope | $68,076 | |
| Original award | $0 |
About this award
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Namu Med, a for-profit sole proprietorship based in South Korea. The contract, valued at $41,666.86, is for the provision of reagents for biochemical antibiotics susceptibility testing to support U.S. military medical facilities in South Korea, primarily the Brian Allgood Army Community Hospital, for the period of October 1, 2023, to September 30, 2024.
Namu Med has an existing Indefinite Delivery Contract (IDC) with the DHA, valued at $1,073,259.72 and running through September 30, 2027, which allows the agency to issue task orders for these specialized medical testing supplies on an as-needed basis. The company has consistently been awarded federal contracts by the DHA and the Department of the Army Medical Command for this purpose, demonstrating its reliability in supporting U.S. military medical laboratories and research programs operating in South Korea. This contract was awarded without any set-aside designation, indicating that Namu Med competes openly in the federal marketplace.
Quick answers
Who was awarded contract W81K0223F0108?
W81K0223F0108 was awarded to Namu Med by Medical Command (Department of the Army) on October 1, 2023.
How much is contract W81K0223F0108 worth?
The government has obligated $41,667 on W81K0223F0108.
Which agency awarded contract W81K0223F0108?
Medical Command (Department of the Army) awarded W81K0223F0108, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0223F0108 an order under another contract?
Yes. W81K0223F0108 is a delivery order under W81K0222D0018, an indefinite delivery contract.
Was contract W81K0223F0108 competed?
The extent of competition for W81K0223F0108 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award